LANXESS Helps Control Insect-Borne Diseases- Saltidin product protects against deadly diseases from mosquitoes, flies and ticks; recommended by World Health Organization - Saltidin’s efficacy to provide up to 14 hours of protection a major differentiator from similar products
By: Maggie Tan Specifically, Saltidin has been recommended by the World Health Organization (WHO) as a substance of choice against mosquito bites transmitting malaria. Insect repellents containing Saltidin are available in most of the countries in different forms and concentrations (5-25%): sprays, lotions, wipes or sticks which are sold, for example, in supermarkets, pharmacies, and drugstores. Depending upon the dosage level, the active formula provides between 3 to 5 hours (10% formula) and up to 14 hours (20% formula) of protection. Saltidin’s efficacy to provide up to 14 hours of protection is a major differentiator from similar products. According to the WHO, dengue haemorrhagic fever affects most Asian countries and has become a leading cause of hospitalization and death among children in the region. Malaria claims almost one million lives per year and afflicts as many as half a billion people in 109 countries in Africa, Asia and Latin America. A child dies from malaria every 30 second. Alvin Gan, LANXESS’s Regional Manager for Basic and Fine Chemicals, ASEAN region, said, “Consumers in Asia are becoming more health conscious and discerning. They are increasingly opting for products which are not only effective but proven to be safe. Saltidin fulfills these requirements.” Saltidin is successfully registered in over 40 countries. This covers important markets, such as the USA, Europe and Asia Pacific. Saltidin – in chemical terms 1-(1-methylpropoxycarbonyl)- The toxicological profile of Saltidin has been extensively evaluated following a program of protocols developed in close cooperation with the US Environmental Protection Agency (EPA). In order to generate the most reliable and consumer relevant data, all studies involved application of Saltidin-containing products to the skin and measured dermal exposure. No adverse outcomes were identified in any studies in the program. It is concluded that Saltidin - is safe when used as indicated - is extremely gentle to the skin and not sticky - has no irritating or sensitizing potential - has a minimal rate of absorption - is suitable for children aged 2 and over The cosmetic properties of Saltidin have also been tested. The results were remarkable: the formulations are not sticky, and have a pleasant feeling, being at the same time safe to use on the skin, as long as the instructions for use are followed. The effect of Saltidin on various materials, like plastics, synthetics, plastic coatings and sealing compounds has been tested, as well. It was found that Saltidin - in contrary to other insect repellents - has no adverse impact on these materials. Saltidin is approved by the US EPA and by countries, such as Sweden, Norway and Denmark, which apply very stringent criteria with respect to environmental and consumer protection. LANXESS is a leader in specialty chemicals with sales in 2008 of EUR 6.58 billion and currently around 14,800 employees in 21 countries. The company has operations at 44 sites worldwide. LANXESS’s core business comprises the development, manufacture and marketing of plastics, rubber, intermediates and specialty chemicals. More information at http://www.lanxessgoesasia.com. # # # LANXESS is a leader in specialty chemicals with sales in 2008 of EUR 6.58 billion and currently around 14,800 employees in 21 countries. The company has operations at 44 sites worldwide. LANXESS’s core business comprises the development, manufacture and marketing of plastics, rubber, intermediates and specialty chemicals. More information at http://www.lanxessgoesasia.com. End
|
|
